Literature DB >> 23539758

Vitamin D status and outcomes after renal transplantation.

Frank Bienaimé1, Delphine Girard, Dany Anglicheau, Guillaume Canaud, Jean Claude Souberbielle, Henri Kreis, Laure Hélène Noël, Gérard Friedlander, Caroline Elie, Christophe Legendre, Dominique Prié.   

Abstract

Kidney transplant recipients usually have low vitamin D levels, especially in the early posttransplantation period, but the association between vitamin D status with renal outcomes is not well described in this population. Here, we studied a prospective cohort of 634 kidney recipients who underwent transplantation at a single institution between January 2005 and June 2010. In this cohort, low 25-hydroxyvitamin D concentrations 3 months after transplantation did not predict early death or graft loss but were independently associated with lower measured GFR at 12 months (P=0.001) and higher risk for interstitial fibrosis and tubular atrophy (P=0.01). In contrast, levels of calcium, phosphorus, calcitriol, parathyroid hormone, or fibroblast growth factor-23 were not consistently associated with any of the studied outcomes. In conclusion, low 25-hydroxyvitamin D concentration measured 3 months after transplantation is an independent risk factor for interstitial fibrosis progression and is associated with a lower GFR 1 year after transplantation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23539758      PMCID: PMC3636791          DOI: 10.1681/ASN.2012060614

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  66 in total

1.  Post-transplant renal function in the first year predicts long-term kidney transplant survival.

Authors:  Sundaram Hariharan; Maureen A McBride; Wida S Cherikh; Christine B Tolleris; Barbara A Bresnahan; Christopher P Johnson
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

2.  Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.

Authors:  R A Wolfe; V B Ashby; E L Milford; A O Ojo; R E Ettenger; L Y Agodoa; P J Held; F K Port
Journal:  N Engl J Med       Date:  1999-12-02       Impact factor: 91.245

3.  Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.

Authors:  V Panichi; M Migliori; D Taccola; C Filippi; L De Nisco; L Giovannini; R Palla; C Tetta; G Camussi
Journal:  Kidney Int       Date:  2001-07       Impact factor: 10.612

4.  22-Oxacalcitriol prevents progressive glomerulosclerosis without adversely affecting calcium and phosphorus metabolism in subtotally nephrectomized rats.

Authors:  Michinori Hirata; Kojiro Makibayashi; Kyoko Katsumata; Kenichiro Kusano; Takeshi Watanabe; Naoshi Fukushima; Toshio Doi
Journal:  Nephrol Dial Transplant       Date:  2002-12       Impact factor: 5.992

5.  A thirty percent chronic decline in inverse serum creatinine is an excellent predictor of late renal allograft failure.

Authors:  Bertram L Kasiske; Magdalena Adeva Andany; Barbara Danielson
Journal:  Am J Kidney Dis       Date:  2002-04       Impact factor: 8.860

6.  1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.

Authors:  Yan Chun Li; Juan Kong; Minjie Wei; Zhou-Feng Chen; Shu Q Liu; Li-Ping Cao
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

7.  25-hydroxyvitamin D(3)-1alpha-hydroxylase expression in normal and pathological parathyroid glands.

Authors:  Ulrika Segersten; Pamela Correa; Martin Hewison; Per Hellman; Henning Dralle; Tobias Carling; Göran Akerström; Gunnar Westin
Journal:  J Clin Endocrinol Metab       Date:  2002-06       Impact factor: 5.958

8.  Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D.

Authors:  Reinhold Vieth; Yasmin Ladak; Paul G Walfish
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

9.  1,25-Dihydroxyvitamin D3 decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat.

Authors:  Alexander Kuhlmann; Christian S Haas; Marie-Luise Gross; Udo Reulbach; Marc Holzinger; Ute Schwarz; Eberhard Ritz; Kerstin Amann
Journal:  Am J Physiol Renal Physiol       Date:  2003-11-04

10.  Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors.

Authors:  Itsuro Endo; Daisuke Inoue; Takao Mitsui; Yoshifumi Umaki; Masashi Akaike; Tatsuya Yoshizawa; Shigeaki Kato; Toshio Matsumoto
Journal:  Endocrinology       Date:  2003-08-13       Impact factor: 4.736

View more
  37 in total

Review 1.  Bone Disease after Kidney Transplantation.

Authors:  Antoine Bouquegneau; Syrazah Salam; Pierre Delanaye; Richard Eastell; Arif Khwaja
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-15       Impact factor: 8.237

2.  Osmoregulation Performance and Kidney Transplant Outcome.

Authors:  Manal Mazloum; Jordan Jouffroy; François Brazier; Christophe Legendre; Antoine Neuraz; Nicolas Garcelon; Dominique Prié; Dany Anglicheau; Frank Bienaimé
Journal:  J Am Soc Nephrol       Date:  2019-06-19       Impact factor: 10.121

Review 3.  Mineral and bone disorder after kidney transplantation.

Authors:  Pahnwat T Taweesedt; Sinee Disthabanchong
Journal:  World J Transplant       Date:  2015-12-24

Review 4.  Vitamin D in patients with chronic kidney disease: a position statement of the Working Group "Trace Elements and Mineral Metabolism" of the Italian Society of Nephrology.

Authors:  Luigi Francesco Morrone; Pergiorgio Bolasco; Corrado Camerini; Giuseppe Cianciolo; Adamasco Cupisti; Andrea Galassi; Sandro Mazzaferro; Domenico Russo; Luigi Russo; Mario Cozzolino
Journal:  J Nephrol       Date:  2016-04-09       Impact factor: 3.902

Review 5.  Current evidence on vitamin D deficiency and kidney transplant: What's new?

Authors:  Gerardo Sarno; Riccardo Nappi; Barbara Altieri; Giacomo Tirabassi; Emanuele Muscogiuri; Gianmaria Salvio; Stavroula A Paschou; Aristide Ferrara; Enrico Russo; Daniela Vicedomini; Cerbone Vincenzo; Andromachi Vryonidou; Silvia Della Casa; Giancarlo Balercia; Francesco Orio; Paride De Rosa
Journal:  Rev Endocr Metab Disord       Date:  2017-09       Impact factor: 6.514

Review 6.  Phosphate and FGF-23 homeostasis after kidney transplantation.

Authors:  Leandro C Baia; Ita Pfeferman Heilberg; Gerjan Navis; Martin H de Borst
Journal:  Nat Rev Nephrol       Date:  2015-09-29       Impact factor: 28.314

7.  Circulating levels of 25-hydroxyvitamin D and acute cellular rejection in kidney allograft recipients.

Authors:  John R Lee; Darshana Dadhania; Phyllis August; Jun B Lee; Manikkam Suthanthiran; Thangamani Muthukumar
Journal:  Transplantation       Date:  2014-08-15       Impact factor: 4.939

Review 8.  Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease.

Authors:  Yoshitsugu Obi; Takayuki Hamano; Yoshitaka Isaka
Journal:  Dis Markers       Date:  2015-03-26       Impact factor: 3.434

Review 9.  Vitamin D in renal transplantation - from biological mechanisms to clinical benefits.

Authors:  R McGregor; G Li; H Penny; G Lombardi; B Afzali; D J Goldsmith
Journal:  Am J Transplant       Date:  2014-05-19       Impact factor: 8.086

Review 10.  Vitamin D status and surgical outcomes: a systematic review.

Authors:  Paul J Iglar; Kirk J Hogan
Journal:  Patient Saf Surg       Date:  2015-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.